クリングルファーマ株式会社.

NEWS

お知らせ


Warning: Invalid argument supplied for foreach() in /home/r3716923/public_html/kringle-pharma.com/wp-content/themes/kringle_pharma/view/single/default.php on line 21
2009.01.28

ChronSeal Phase I/II started in Sweden PDF

Kringle Pharma Commences a Phase I/II Clinical Trial in Sweden on ChronSeal®, a Recombinant Human HGF-Based Therapy for the Treatment of Skin Ulcers.